STERIPLEX® SD is the First and OnlyEPA-Registered C. diff Sporicide, Tuberculocide, Bactericide, Virucide, and Fungicide that is:Non-CorrosiveNon-FumingNon-ToxicNo VOC’s Acceptable for “Touchless Spray”

Application

Unprecedented Efficacy, based on Steriplex Ultra, the only EPA-approved Anthrax Sporicide

STERIPLEX® SD EPA-approved Sporicide for Hospital Use, providing a 6 log (99.9999%) kill of C. diff spores in only 5 minutes – without Bleach

C. difficile is associated with: An increased length of stay in healthcare facilities up to 4.5 days Inpatient care costs have been estimated to be $2,500 to $3,500 per patient (excluding costs associated with surgical interventions) Economic consequences in US exceeds $3.2 billion annually

C. difficile produces spores that can: Persist in the environment for many months and are highly resistant to

cleaning and disinfection measures Exist for five months on hard surfacesGuide to the Elimination of Clostridium difficile in Healthcare Settings, APIC Guide 2008

C. difficile – A Problem in the Hospital Environment

Endospores (C. diff) Mycobacterium/acid-fast bacilli (TB) Naked virus (Norovirus, Parvovirus, Adenovirus-colds, Polio, Hepatitis) Gram-negative bacteri (Pseudomonas, Klebsiella pneumoniae, Legionella,

STDs, E. coli etc.) Gram-positive bacteria (C. diff, Bacillus, Staph…including

MRSA, Strep, Listeria) Fungi, molds & yeast Enveloped viruses (HIV, Herpes-dsDNA, Influenza A/B/C-ss RNA,

Bird Flu Poxvirus-Smallpox, Rabies)

Acinetobacter baumanii Aspergillus brasiliensis (Black Mold) Avian Influenza A Virus Clostridium difficile (C. diff.) spores Enterobacter sakazakii Escherichia coli Escherichia coli O157:H7 Hepatitis B Virus (HBV) HIV-1 (AIDS Virus) Human Influenza A Virus Herpes Simplex Virus Type 1 (HSV-1) Influenza A (H1N1) Pandemic Swine Flu Klebsiella pneumonia (NDM-1*) Listeria monocytogenes

Methicillin-Resistant Staph. (MRSA*)

Murine Norovirus Mycobacterium bovis BCG (Tuberculocide) Norovirus Feline Calicivirus (FCV) Poliovirus Pseudomonas aeruginosa Respiratory Syncytial Virus (RSV) Salmonella enterica Salmonella typhimurium SARS-Associated Coronavirus Staphylococcus aureus Trichophyton mentagrophytes (Athlete's Foot) Vancomycin-Resistant Enterococcus (VRE*) Vibrio cholerae

Including drug resistant strains*

STERIPLEX® SD exhibits a clean, fresh smell, with:No BleachNo QuatsNo AmmoniaNo PhenolNo PhosphatesNo AldehydesNo Toxic Fumes or VOC’s

Replaces the Need for Multiple Chemicals

Reduces Total Applied Costs Reduces Time and Labor No Rinse Required, HMIS = “0”

Greatly Reduce Costs Associated with HAI’s

Decrease Exposure to Chemicals Eliminate Material, Equipment and

Surface Damage May Be Used With Patients in Room

C. diff Sporicide, Bactericide, Virucide, Fungicide, Tuberculocide, Germicide One-Step Sporicide-Cleaner-Disinfectant-Deodorizer, No Rinse Required One Product “Does It All” – Floors, Walls, Surfaces, Equipment, Throughout

the Healthcare Environment May be used while Patients are in the Room Supports Green Initiatives and Sustainability Programs with HMIS rating = “0” STERIPLEX® SD is up to 15 times more Effective than Bleach in Denaturing DNA

Infection Control Confidence, Patient and Hospital Staff Safety

Ideal for Sensitive Instruments, Equipment & Areas STERIPLEX® SD is Ideal for Water Sensitive Equipment & Areas Helps Reduce Cross Contamination of Treated Hard, Non-porous Surfaces STERIPLEX® SD is Non-Corrosive Superior materials compatibility including: Stainless

Steel, Chrome, Plastic, Silicone Rubber, Metal,

Medical Tubing, Vinyl Rubber, Laminated Surfaces,

Glass, Acrylic Plastic, Plexiglas®, Sealed Fiberglass,

Ceramic, Glazed Enamel, Glazed Porcelain, Corian®,

Formica, Sealed Granite, Sealed Limestone & More

Gallon:Trigger Spraying

Touchless Application

Wipes: 7” x 6” 12” X 9”

STERIPLEX SD can be applied using new “touchless spray” methods in almost any environment with significant labor cost savings compared to traditional manual methods of application. Applications requiring hours can be reduced to minutes!

High Touch Surfaces, High Risk and Hard to Reach Areas, Crevices & Shadows

Clostridium Difficile Spores

Q4-11 Total Q1-12 Total Apr-120

0.2

0.4

0.6

0.8

1

1.2

BMT

Extended Spectrum Beta Lactamase bacteria-E. coli, Klebsiella

Q4-11

Tot

al

Q1-12

Tot

al

Apr-1

20

0.51

1.52

2.5

VRE

VRE (Vancomycin Resistant Bacteria)

Huntsman Cancer Hospital, Bone Marrow Transplant UnitSteriplex StudyApril 2012

Thank you for your time!